| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/0008-5472.CAN-04-2253 |
| P8608 | Fatcat ID | release_pzowzeejazctxc7usdmxwqxhwm |
| P698 | PubMed publication ID | 15930279 |
| P2093 | author name string | Lurong Zhang | |
| Shanmin Yang | |||
| Xue-Ming Xu | |||
| Yixin Chen | |||
| Charles B Underhill | |||
| Jinguo Chen | |||
| Karen Creswell | |||
| Luping Wang | |||
| Shuigen Hong | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4614-4622 | |
| P577 | publication date | 2005-06-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Tachyplesin activates the classic complement pathway to kill tumor cells | |
| P478 | volume | 65 |
| Q64897896 | ACPred: A Computational Tool for the Prediction and Analysis of Anticancer Peptides. |
| Q33260522 | Acyl-substituted dermaseptin S4 derivatives with improved bactericidal properties, including on oral microflora |
| Q38128298 | Antimicrobial peptides: versatile biological properties |
| Q39928986 | Aptamer–biotin–streptavidin–C1q complexes can trigger the classical complement pathway to kill cancer cells |
| Q92906753 | Characterization of Tachyplesin Peptides and Their Cyclized Analogues to Improve Antimicrobial and Anticancer Properties |
| Q38694731 | Comparative in vitro study on cytotoxicity of recombinant β-hairpin peptides. |
| Q51253671 | Comparison of Cytotoxic Activity in Leukemic Lineages Reveals Important Features of β-Hairpin Antimicrobial Peptides. |
| Q33457187 | Complement C1q activates tumor suppressor WWOX to induce apoptosis in prostate cancer cells |
| Q38160482 | Current scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral peptides |
| Q42280878 | Design of NK-2-derived peptides with improved activity against equine sarcoid cells |
| Q53743069 | Effect of N- and C-Terminal Modifications on Cytotoxic Properties of Antimicrobial Peptide Tachyplesin I. |
| Q37207728 | From antimicrobial to anticancer peptides. A review |
| Q34302997 | Gene interaction enrichment and network analysis to identify dysregulated pathways and their interactions in complex diseases |
| Q46047892 | High-level Expression of Cecropin X in Escherichia coli |
| Q28828941 | Identifying anticancer peptides by using improved hybrid compositions |
| Q41390340 | Impact of self-assembly properties on antibacterial activity of short acyl-lysine oligomers |
| Q60922981 | Modulation of Human Complement System by Antimicrobial Peptide Arenicin-1 from |
| Q35600198 | Oncolytic activities of host defense peptides |
| Q35180291 | Prognostic stromal gene signatures in breast cancer. |
| Q37628648 | Quantitative Proteomic Profiling of Tachyplesin I Targets in U251 Gliomaspheres |
| Q35060387 | Resistance to degradation and cellular distribution are important features for the antitumor activity of gomesin |
| Q35879590 | Retrocyclins and their activity against HIV-1. |
| Q28548620 | Scalable Production of Recombinant Membrane Active Peptides and Its Potential as a Complementary Adjunct to Conventional Chemotherapeutics |
| Q38450909 | Structure and Biological Functions of β-Hairpin Antimicrobial Peptides |
| Q24650885 | Studies on anticancer activities of antimicrobial peptides |
| Q35884337 | Targeted delivery of a proapoptotic peptide to tumors in vivo. |
| Q37909101 | The antibacterial peptide ABP-CM4: the current state of its production and applications |
| Q90042170 | The bacterial instrument as a promising therapy for colon cancer |
| Q41872268 | Toxicological analysis of low-nicotine and nicotine-free cigarettes |
| Q46326633 | Tumor cell membrane-targeting cationic antimicrobial peptides: novel insights into mechanisms of action and therapeutic prospects |
Search more.